Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maxing Xuanfei Zhike patch is a Traditional Chinese Medicine (TCM) transdermal patch developed by Hubei Youersheng Pharmaceutical for the treatment of acute bronchitis, specifically targeting pediatric patients with wind-heat invading the lung syndrome. The formulation is derived from the classic Ma Xing Shi Gan decoction, containing active ingredients from *Ephedra sinica*, *Prunus armeniaca*, *Gypsum fibrosum*, and *Glycyrrhiza uralensis*. It functions by ventilating the lungs, clearing heat, and suppressing cough. By utilizing a transdermal patch delivery system, it avoids the challenges of oral administration in children and provides a steady release of herbal constituents to alleviate bronchial inflammation and cough.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Maxing Xuanfei Zhike patch.